Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by V. Skihar
Promoting Oligodendrogenesis and Myelin Repair Using the Multiple Sclerosis Medication Glatiramer Acetate
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Related publications
Promoting Myelin Repair and Return of Function in Multiple Sclerosis
FEBS Letters
Genetics
Cell Biology
Molecular Biology
Biochemistry
Structural Biology
Biophysics
Glatiramer Acetate in the Reduction of Relapse Frequency in Multiple Sclerosis
Clinical Medicine Insights: Therapeutics
Medicine
Pharmacology
Pharmaceutical Science
Clinical Utility of Glatiramer Acetate in the Management of Relapse Frequency in Multiple Sclerosis
Journal of Central Nervous System Disease
Pnd12 - Natalizumab Versus Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis: A Network Meta-Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Differential Transcription of SOCS5 and SOCS7 in Multiple Sclerosis Patients Treated With Interferon Beta or Glatiramer Acetate
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Assessing the Long-Term Effectiveness of Interferon-Beta and Glatiramer Acetate in Multiple Sclerosis: Final 10-Year Results From the UK Multiple Sclerosis Risk-Sharing Scheme
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
Risks vs Benefits of Glatiramer Acetate: A Changing Perspective as New Therapies Emerge for Multiple Sclerosis
Therapeutics and Clinical Risk Management
Cost-Effectiveness of Glatiramer Acetate and Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis, Based on the Combirx Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Examining the Influence of Behavioral Factors on Compliance and Persistence With Glatiramer Acetate Injection for Relapsing-Remitting Multiple Sclerosis
Journal of Neurology & Neurophysiology